Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Y T Chen

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
The Journal of Urology|September 18, 2009
Editorial commentDavid Y T Chen
The Medical Clinics of North America|November 25, 2010
Evaluation and management of the renal massDavid Y T Chen, Robert G Uzzo
The Journal of Urology|November 13, 2016
Editorial CommentShreyas S Joshi, David Y T Chen
Journal of the National Comprehensive Cancer Network : JNCCN|June 27, 2009
Optimal management of localized renal cell carcinoma: surgery, ablation, or active surveillanceDavid Y T Chen, Robert G Uzzo
World Journal of Urology|April 9, 2014
Thinking beyond surgery in the management of renal cell carcinoma: the risk to die from renal cell carcinoma and competing risks of deathDavid Y T Chen, Robert G Uzzo, Rosalia Viterbo
Current Urology Reports|January 22, 2004
Treatment of adrenocortical carcinoma: contemporary outcomesDavid Y T Chen, R Ernest Sosa, Douglas S Scherr
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 25, 2014
Does family history of prostate cancer affect outcomes following radiotherapy?Hilary Bagshaw, Karen Ruth, Eric M Horwitz, et al.
Urologic Oncology|September 9, 2008
Predicting growth of solid renal masses under active surveillancePaul L Crispen, Yu-Ning Wong, Richard E Greenberg, et al.
BJU International|August 14, 2013
Validation of association of genetic variants at 10q with prostate-specific antigen (PSA) levels in men at high risk for prostate cancerBao-Li Chang, Lucinda Hughes, David Y T Chen, et al.
The Journal of Urology|February 14, 2007
Enhancing renal masses with zero net growth during active surveillanceDavid A Kunkle, Paul L Crispen, David Y T Chen, et al.
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
The Journal of Urology|September 18, 2009
Editorial commentDavid Y T Chen
The Medical Clinics of North America|November 25, 2010
Evaluation and management of the renal massDavid Y T Chen, Robert G Uzzo
The Journal of Urology|November 13, 2016
Editorial CommentShreyas S Joshi, David Y T Chen
Journal of the National Comprehensive Cancer Network : JNCCN|June 27, 2009
Optimal management of localized renal cell carcinoma: surgery, ablation, or active surveillanceDavid Y T Chen, Robert G Uzzo
World Journal of Urology|April 9, 2014
Thinking beyond surgery in the management of renal cell carcinoma: the risk to die from renal cell carcinoma and competing risks of deathDavid Y T Chen, Robert G Uzzo, Rosalia Viterbo
Current Urology Reports|January 22, 2004
Treatment of adrenocortical carcinoma: contemporary outcomesDavid Y T Chen, R Ernest Sosa, Douglas S Scherr
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 25, 2014
Does family history of prostate cancer affect outcomes following radiotherapy?Hilary Bagshaw, Karen Ruth, Eric M Horwitz, et al.
Urologic Oncology|September 9, 2008
Predicting growth of solid renal masses under active surveillancePaul L Crispen, Yu-Ning Wong, Richard E Greenberg, et al.
BJU International|August 14, 2013
Validation of association of genetic variants at 10q with prostate-specific antigen (PSA) levels in men at high risk for prostate cancerBao-Li Chang, Lucinda Hughes, David Y T Chen, et al.
The Journal of Urology|February 14, 2007
Enhancing renal masses with zero net growth during active surveillanceDavid A Kunkle, Paul L Crispen, David Y T Chen, et al.
Pageof 13